0 Shares 203 Views

The Oxford COVID-19 vaccine is 'progressing very well,' according to the lead scientists, who said 10,000 more people will be inoculated

May 22, 2020
0 204
Radcliffe Camera Oxford University EnglandRadcliffe Camera Oxford University England
The Radcliffe Camera, part of the main library at Oxford University, England.

Wikimedia Commons

  • The head of the Oxford Vaccine Group said Friday that clinic trials on its vaccine for the coronavirus are “progressing very well.” 
  • 1,000 people have already been inoculated. The next stage will see 10,000 more given the treatment through May and June, Andrew Pollard said.
  • The trial vaccine is called as AZD1222 or ChAdOx1 nCoV-19. It was first tested on humans on April 23, following success in macaque monkeys.
  • The group said they hoped for clinical test results in two months, but that it could take as long as six. 
  • Visit Business Insider’s homepage for more stories.

The head of the Oxford Vaccine Group said Friday that its clinical trials are “progressing very well” and that the program will inoculate 10,000 new people.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content=""We are now initiating studies to evaluate how well the vaccine induces immune responses in older adults," Professor Andrew Pollard, head of the Oxford Vaccine Group, said in a press release.” data-reactid=”25″>”We are now initiating studies to evaluate how well the vaccine induces immune responses in older adults,” Professor Andrew Pollard, head of the Oxford Vaccine Group, said in a press release.

‘The clinical studies are progressing very well.”

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The trial vaccine is called AZD1222 or ChAdOx1 nCoV-19. It was first tested on two humans&nbsp;on April 23 in Oxford, following promising results on six macaque monkeys in the US in March.” data-reactid=”27″>The trial vaccine is called AZD1222 or ChAdOx1 nCoV-19. It was first tested on two humans on April 23 in Oxford, following promising results on six macaque monkeys in the US in March.

1,000 people have since been given the trial vaccine across the UK, but children and those over 55 were excluded.

10,260 new people, including the elderly, will be given the trial vaccine in May and June, the group said. Subjects keep a diary and submit regular blood samples.

oxford vaccine group trialoxford vaccine group trial
The first human trial of the ChAdOx1 nCoV-19. vaccine from the Oxford Vaccine Group.

YouTube/University of Oxford

The group said that results would be available “in a couple of months,” but that “it could take up to six months” depending on outside factors.

Progress could be slowed if the UK coronavirus outbreak slows down, because it means fewer test subjects will be exposed naturally to the virus.

To mitigate this potential issue, the group is prioritizing volunteers with “a higher chance of being exposed,” like frontline healthcare workers.

The Oxford Vaccine Group is one of a few elite laboratories and facilities leading the race to find a vaccine.

OXFORD, ENGLAND - APRIL 29: A general view of a sign outside of the University of Oxford Old Road Campus, which houses the Jenner Institute and is where the first human trials of a coronavirus vaccine developed by researchers at the University of Oxford is taking place in Oxford, England on April 29, 2020. British Prime Minister Boris Johnson, who returned to Downing Street this week after recovering from Covid-19, said the country needed to continue its lockdown measures to avoid a second spike in infections. (Photo by Getty Images)OXFORD, ENGLAND - APRIL 29: A general view of a sign outside of the University of Oxford Old Road Campus, which houses the Jenner Institute and is where the first human trials of a coronavirus vaccine developed by researchers at the University of Oxford is taking place in Oxford, England on April 29, 2020. British Prime Minister Boris Johnson, who returned to Downing Street this week after recovering from Covid-19, said the country needed to continue its lockdown measures to avoid a second spike in infections. (Photo by Getty Images)
A sign outside of the University of Oxford Old Road Campus, where a coronavirus vaccine is developed by the University of Oxford, England on April 29, 2020.

Getty

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="On Monday, the US-based firm Moderna tentatively said that all 45 people given its trial vaccine had created immune responses that could help protect them from the coronavirus.” data-reactid=”58″>On Monday, the US-based firm Moderna tentatively said that all 45 people given its trial vaccine had created immune responses that could help protect them from the coronavirus.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Dr Anthony Fauci, the director of the National Institute on Allergy and Infectious Disease said he was "cautiously optimistic about it."” data-reactid=”59″>Dr Anthony Fauci, the director of the National Institute on Allergy and Infectious Disease said he was “cautiously optimistic about it.”

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The drugs giant Pfizer, who are partnered with BioNTech, began trialling its BNT162 vaccine on humans on May 5. It is yet to announce preliminary results.” data-reactid=”60″>The drugs giant Pfizer, who are partnered with BioNTech, began trialling its BNT162 vaccine on humans on May 5. It is yet to announce preliminary results.

A scientist checks quality control of vaccine vials for correct volume at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020. Sean Elias/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. NO RESALES. NO ARCHIVESA scientist checks quality control of vaccine vials for correct volume at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020. Sean Elias/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. NO RESALES. NO ARCHIVES
A scientist checks vaccine vials for correct volume at the Clinical Biomanufacturing Facility (CBF) in Oxford, UK, on April 2, 2020.

Sean Elias/Handout via REUTERS

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="In total, 12 vaccines in development around the world are in the human trial stage, according to The Associated Press.” data-reactid=”73″>In total, 12 vaccines in development around the world are in the human trial stage, according to The Associated Press.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Sarah Gilbert, a professor of vaccinology working on the Oxford vaccine said on April 11 that the earliest it could be ready was September, but that such a date was very optimistic.” data-reactid=”74″>Sarah Gilbert, a professor of vaccinology working on the Oxford vaccine said on April 11 that the earliest it could be ready was September, but that such a date was very optimistic.

Whether the vaccine is approved or not, it is already in high demand.

Photo taken on May 18, 2020 shows a logo in front of AstraZeneca's building in Luton, Britain. The Oxford University has confirmed aPhoto taken on May 18, 2020 shows a logo in front of AstraZeneca's building in Luton, Britain. The Oxford University has confirmed a
The AstraZeneca building in Luton, Britain.

Getty

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The Oxford Vaccine Group is partnered with pharmaceuticals giant AstraZeneca, and on Thursday, the US government&nbsp;agreed to pay up to $1.2 billion for 300 million doses of the vaccine” data-reactid=”88″>The Oxford Vaccine Group is partnered with pharmaceuticals giant AstraZeneca, and on Thursday, the US government agreed to pay up to $1.2 billion for 300 million doses of the vaccine

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Last month, the world's largest vaccine maker by doses, The Serum Institute of India, said it too would manufacture 40 million doses, without yet knowing whether it works.” data-reactid=”89″>Last month, the world’s largest vaccine maker by doses, The Serum Institute of India, said it too would manufacture 40 million doses, without yet knowing whether it works.

“The decision — at our own risk and cost — has been solely taken to get a jump-start on manufacturing,” CEO Adar Poonawalla said.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Despite the progress, there are concerns that even when a vaccine becomes available, a global rollout will be hampered by a shortage of the glass vials and lids necessary to distribute the product.” data-reactid=”91″>Despite the progress, there are concerns that even when a vaccine becomes available, a global rollout will be hampered by a shortage of the glass vials and lids necessary to distribute the product.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Read the original article on Business Insider” data-reactid=”92″>Read the original article on Business Insider

You may be interested

Biden rows back from embarrassing interview where he said Latinos are 'incredibly diverse' unlike African-Americans
Entertainment
23 views
Entertainment
23 views

Biden rows back from embarrassing interview where he said Latinos are 'incredibly diverse' unlike African-Americans

Webby - August 7, 2020

Democratic presidential candidate Joe Biden in Lancaster, Pennsylvania, on June 25, 2020.JIM WATSON/AFP via Getty ImagesJoe Biden rowed back comments suggesting that African-Americans as a group do…

Man fights with bear after it enters home with 10 kids inside, Alaska officials say
Entertainment
43 views
Entertainment
43 views

Man fights with bear after it enters home with 10 kids inside, Alaska officials say

Webby - August 7, 2020

An Alaska man went toe-to-toe with a home-intruding black bear, outlets report, putting himself between 10 children and the 300-pound predator that wandered into the living room.The…

Minneapolis leaders push ahead with efforts to change police
Entertainment
37 views
Entertainment
37 views

Minneapolis leaders push ahead with efforts to change police

Webby - August 6, 2020

MINNEAPOLIS (AP) — Minneapolis leaders who pledged to dismantle the city’s Police Department in the wake of George Floyd’s death won’t achieve the type of structural overhaul…

Leave a Comment

Your email address will not be published.

Most from this category